Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Corrigendum: Ex vivo modulatio...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Thomas Morgan Hulen, Christina Friese, Nikolaj Pagh Kristensen, Joachim Stoltenborg Granhøj, Troels Holz Borch, Marlies J. W. Peeters, Marco Donia, Mads Hald Andersen, Sine Reker Hadrup, Inge Marie Svane, Özcan Met
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Subjects:
tumor-infiltrating lymphocyte (TIL)
checkpoint inhibition
metastatic melanoma
cancer immunotherapy
tumor microenevironment
adoptive cell immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1462081/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1462081/full

Similar Items

  • Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes
    by: Thomas Morgan Hulen, et al.
    Published: (2023-06-01)
  • ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors
    by: Thomas Morgan Hulen, et al.
    Published: (2021-07-01)
  • Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
    by: Mohammad Hossein Kazemi, et al.
    Published: (2022-10-01)
  • Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
    by: Biaoru Li
    Published: (2022-10-01)
  • Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis
    by: Sumon Mukherjee, et al.
    Published: (2025-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs